Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dual therapy aims to beat stomach bug with fewer pills

NCT ID NCT06734260

First seen Jan 02, 2026 · Last updated May 19, 2026 · Updated 22 times

Summary

This study tests a new two-drug combination (keverprazan and amoxicillin) to treat H. pylori, a stomach infection that can cause ulcers and cancer. About 477 adults will receive different doses and treatment lengths (10 or 14 days) to find the best balance of effectiveness, fewer side effects, and lower cost. The goal is to replace current four-drug regimens that often cause more side effects and are harder to follow.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI ERADICATION RATE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eighth Affiliated Hospital,Sun Yet-san University

    RECRUITING

    Shenzhen, Guangdong, 518033, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Puning Overseas Chinese Hospital

    RECRUITING

    Puning, Guangdong, 515300, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Sixth Affiliated Hospital of Sun Yat-sen University

    RECRUITING

    Guangzhou, Guangdong, 510655, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Xiangyang Hospital of Traditional Chinese Medicine

    RECRUITING

    Xiangyang, Hubei, 441000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.